Importer of Controlled Substances Application: Medi-Physics Inc. DBA GE Healthcare, 8718-8719 [2025-02014]
Download as PDF
<![CDATA[
8718
Federal Register / Vol. 90, No. 20 / Friday, January 31, 2025 / Notices
Melbourne, FL; FlexCompute Inc.,
Watertown, MA; MPI America Inc., San
Jose, CA; Phlotonics, Inc., Rochester,
NY; PICadvanced US LLC, Fort
Lauderdale, FL; and Research
Foundation on behalf of the University
at Albany, Albany, NY, have been added
as parties to this venture.
Also, AAYUNA Inc., Allentown, PA;
Trustees of Boston University, Boston,
MA; Ebara Technologies, Inc.,
Sacramento, CA; George Washington
University, Washington, DC; Presco
Engineering, Woodbridge, CT; Teledyne
Princeton Instruments, Trenton, NJ; and
Milkshake Technology Inc., Menlo Park,
CA, have withdrawn as parties to this
venture.
No other changes have been made in
either the membership or planned
activity of the group research project.
Membership in this group research
project remains open, and AIM
Photonics intends to file additional
written notifications disclosing all
changes in membership.
On June 16, 2016, AIM Photonics
filed its original notification pursuant to
section 6(a) of the Act. The Department
of Justice published a notice in the
Federal Register pursuant to section
6(b) of the Act on July 25, 2016 (81 FR
48450).
The last notification was filed with
the Department on July 1, 2024. A
notice was published in the Federal
Register pursuant to section 6(b) of the
Act on September 26, 2024 (89 FR
78903).
Suzanne Morris,
Deputy Director Civil Enforcement
Operations, Antitrust Division.
the issuance of the proposed registration
on or before April 1, 2025. Such persons
may also file a written request for a
hearing on the application on or before
April 1, 2025.
The Drug Enforcement
Administration requires that all
comments be submitted electronically
BILLING CODE P
through the Federal eRulemaking Portal,
which provides the ability to type short
DEPARTMENT OF JUSTICE
comments directly into the comment
field on the web page or attach a file for
Drug Enforcement Administration
lengthier comments. Please go to
https://www.regulations.gov and follow
[Docket No. DEA–1481]
the online instructions at that site for
Bulk Manufacturer of Controlled
submitting comments. Upon submission
Substances Application: Organic
of your comment, you will receive a
Consultants LLC DBA Cascade
Comment Tracking Number. Please be
Chemistry
aware that submitted comments are not
instantaneously available for public
AGENCY: Drug Enforcement
view on https://www.regulations.gov. If
Administration, Justice.
you have received a Comment Tracking
ACTION: Notice of application.
Number, your comment has been
successfully submitted and there is no
SUMMARY: Organic Consultants LLC DBA
need to resubmit the same comment.
Cascade Chemistry has applied to be
registered as a bulk manufacturer of
SUPPLEMENTARY INFORMATION: In
basic class(es) of controlled
accordance with 21 CFR 1301.33(a), this
substance(s). Refer to SUPPLEMENTARY
is notice that on November 26, 2024,
INFORMATION listed below for further
Organic Consultants LLC DBA Cascade
drug information.
Chemistry, 90 North Polk Street, Suite
DATES: Registered bulk manufacturers of 200, Eugene, Oregon 97402–4109
applied to be registered as a bulk
the affected basic class(es), and
manufacturer of the following basic
applicants, therefore, may submit
electronic comments on or objections to class(es) of controlled substance(s):
ADDRESSES:
[FR Doc. 2025–02044 Filed 1–30–25; 8:45 am]
Controlled substance
Drug code
ddrumheller on DSK120RN23PROD with NOTICES1
Amphetamine ...................................................................................................................................................................
Methylphenidate ..............................................................................................................................................................
Codeine ...........................................................................................................................................................................
Oxycodone .......................................................................................................................................................................
Hydromorphone ...............................................................................................................................................................
Hydrocodone ...................................................................................................................................................................
Meperidine .......................................................................................................................................................................
Meperidine intermediate-A ..............................................................................................................................................
Meperidine intermediate-B ..............................................................................................................................................
Meperidine intermediate-C ..............................................................................................................................................
Methadone .......................................................................................................................................................................
Methadone intermediate ..................................................................................................................................................
Morphine ..........................................................................................................................................................................
Thebaine ..........................................................................................................................................................................
Oxymorphone ..................................................................................................................................................................
Noroxymorphone .............................................................................................................................................................
Fentanyl ...........................................................................................................................................................................
The company plans to bulk
manufacture small quantities of the
listed controlled substances for internal
use or for sale as analytical reference
standard materials to its customers. No
other activities for these drug codes are
authorized for this registration.
Matthew Strait,
Deputy Assistant Administrator.
[FR Doc. 2025–02008 Filed 1–30–25; 8:45 am]
BILLING CODE P
VerDate Sep<11>2014
18:17 Jan 30, 2025
Jkt 265001
Drug Enforcement Administration
[Docket No. DEA–1483]
Importer of Controlled Substances
Application: Medi-Physics Inc. DBA GE
Healthcare
Drug Enforcement
Administration, Justice.
ACTION: Notice of application.
PO 00000
Frm 00025
Fmt 4703
Sfmt 4703
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
Medi-Physics Inc. DBA GE
Healthcare has applied to be registered
as an importer of basic class(es) of
controlled substance(s). Refer to
SUPPLEMENTARY INFORMATION listed
below for further drug information.
SUMMARY:
DEPARTMENT OF JUSTICE
AGENCY:
1100
1724
9050
9143
9150
9193
9230
9232
9233
9234
9250
9254
9300
9333
9652
9668
9801
Schedule
Registered bulk manufacturers of
the affected basic class(es), and
applicants, therefore, may submit
electronic comments on or objections to
the issuance of the proposed registration
on or before March 3, 2025. Such
DATES:
E:\FR\FM\31JAN1.SGM
31JAN1
8719
Federal Register / Vol. 90, No. 20 / Friday, January 31, 2025 / Notices
persons may also file a written request
for a hearing on the application on or
before March 3, 2025.
The Drug Enforcement
Administration requires that all
comments be submitted electronically
through the Federal eRulemaking Portal,
which provides the ability to type short
comments directly into the comment
field on the web page or attach a file for
lengthier comments. Please go to
https://www.regulations.gov and follow
the online instructions at that site for
submitting comments. Upon submission
of your comment, you will receive a
Comment Tracking Number. Please be
aware that submitted comments are not
instantaneously available for public
view on https://www.regulations.gov. If
you have received a Comment Tracking
Number, your comment has been
successfully submitted and there is no
need to resubmit the same comment. All
requests for a hearing must be sent to:
(1) Drug Enforcement Administration,
Attn: Hearing Clerk/OALJ, 8701
Morrissette Drive, Springfield, Virginia
22152; and (2) Drug Enforcement
Administration, Attn: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for a hearing should
also be sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152.
ADDRESSES:
In
accordance with 21 CFR 1301.34(a), this
is notice that on December 16, 2024,
Medi-Physics Inc. DBA GE Healthcare,
3350 North Ridge Avenue, Arlington
Heights, Illinois 60004–1412, applied to
be registered as an importer of the
following basic class(es) of controlled
substance(s):
SUPPLEMENTARY INFORMATION:
Controlled substance
Cocaine ..........................
Ecgonine .........................
I
Drug
code
Schedule
9041
9180
II
II
I
The company plans to import
derivatives of the listed controlled
substances to be used for the
manufacture of a diagnostic product and
reference standards. No other activities
for these drug codes are authorized for
this registration.
Approval of permit applications will
occur only when the registrant’s
business activity is consistent with what
is authorized under 21 U.S.C. 952(a)(2).
Authorization will not extend to the
import of Food and Drug
Administration-approved or nonapproved finished dosage forms for
commercial sale.
Matthew Strait,
Deputy Assistant Administrator.
[FR Doc. 2025–02014 Filed 1–30–25; 8:45 am]
BILLING CODE P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–1482]
Importer of Controlled Substances
Application: Catalent Greenville, Inc.
Drug Enforcement
Administration, Justice.
ACTION: Notice of application.
AGENCY:
Catalent Greenville, Inc. has
applied to be registered as an importer
of basic class(es) of controlled
substance(s). Refer to SUPPLEMENTARY
INFORMATION listed below for further
drug information.
DATES: Registered bulk manufacturers of
the affected basic class(es), and
applicants, therefore, may submit
SUMMARY:
electronic comments on or objections to
the issuance of the proposed registration
on or before March 3, 2025. Such
persons may also file a written request
for a hearing on the application on or
before March 3, 2025.
The Drug Enforcement
Administration requires that all
comments be submitted electronically
through the Federal eRulemaking Portal,
which provides the ability to type short
comments directly into the comment
field on the web page or attach a file for
lengthier comments. Please go to
https://www.regulations.gov and follow
the online instructions at that site for
submitting comments. Upon submission
of your comment, you will receive a
Comment Tracking Number. Please be
aware that submitted comments are not
instantaneously available for public
view on https://www.regulations.gov. If
you have received a Comment Tracking
Number, your comment has been
successfully submitted and there is no
need to resubmit the same comment. All
requests for a hearing must be sent to:
(1) Drug Enforcement Administration,
Attn: Hearing Clerk/OALJ, 8701
Morrissette Drive, Springfield, Virginia
22152; and (2) Drug Enforcement
Administration, Attn: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for a hearing should
also be sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152.
ADDRESSES:
In
accordance with 21 CFR 1301.34(a), this
is notice that on November 27, 2024,
Catalent Greenville, Inc., 1240 Sugg
Parkway, Greenville, North Carolina
27834–9006, applied to be registered as
an importer of the following basic
class(es) of controlled substance(s):
SUPPLEMENTARY INFORMATION:
Controlled substance
Drug code
ddrumheller on DSK120RN23PROD with NOTICES1
3,4-Methylenedioxymethamphetamine ............................................................................................................................
The company plans to import the
listed controlled substance for the
development of bulk dosage
formulations for research, clinical trial
studies and analytical purposes. No
other activity for this drug code is
authorized for this registration.
Approval of permit applications will
occur only when the registrant’s
business activity is consistent with what
is authorized under 21 U.S.C. 952(a)(2).
Authorization will not extend to the
import of Food and Drug
Administration-approved or non-
VerDate Sep<11>2014
18:17 Jan 30, 2025
Jkt 265001
approved finished dosage forms for
commercial sale.
Matthew Strait,
Deputy Assistant Administrator.
[FR Doc. 2025–02013 Filed 1–30–25; 8:45 am]
BILLING CODE P
PO 00000
7405
Schedule
I
DEPARTMENT OF JUSTICE
[OMB Number 1121–0269]
Agency Information Collection
Activities; Proposed eCollection
eComments Requested;
Reinstatement, With Change, of a
Previously Approved Collection for
Which Approval Has Expired: Census
of Publicly Funded Forensic Crime
Laboratories (CPFFCL)
Bureau of Justice Statistics,
Department of Justice.
AGENCY:
Frm 00026
Fmt 4703
Sfmt 4703
E:\FR\FM\31JAN1.SGM
31JAN1
]]>Agencies
[Federal Register Volume 90, Number 20 (Friday, January 31, 2025)]
[Notices]
[Pages 8718-8719]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2025-02014]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-1483]
Importer of Controlled Substances Application: Medi-Physics Inc.
DBA GE Healthcare
AGENCY: Drug Enforcement Administration, Justice.
ACTION: Notice of application.
-----------------------------------------------------------------------
SUMMARY: Medi-Physics Inc. DBA GE Healthcare has applied to be
registered as an importer of basic class(es) of controlled
substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for
further drug information.
DATES: Registered bulk manufacturers of the affected basic class(es),
and applicants, therefore, may submit electronic comments on or
objections to the issuance of the proposed registration on or before
March 3, 2025. Such
[[Page 8719]]
persons may also file a written request for a hearing on the
application on or before March 3, 2025.
ADDRESSES: The Drug Enforcement Administration requires that all
comments be submitted electronically through the Federal eRulemaking
Portal, which provides the ability to type short comments directly into
the comment field on the web page or attach a file for lengthier
comments. Please go to https://www.regulations.gov and follow the
online instructions at that site for submitting comments. Upon
submission of your comment, you will receive a Comment Tracking Number.
Please be aware that submitted comments are not instantaneously
available for public view on https://www.regulations.gov. If you have
received a Comment Tracking Number, your comment has been successfully
submitted and there is no need to resubmit the same comment. All
requests for a hearing must be sent to: (1) Drug Enforcement
Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive,
Springfield, Virginia 22152; and (2) Drug Enforcement Administration,
Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive,
Springfield, Virginia 22152. All requests for a hearing should also be
sent to: Drug Enforcement Administration, Attn: Administrator, 8701
Morrissette Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.34(a), this
is notice that on December 16, 2024, Medi-Physics Inc. DBA GE
Healthcare, 3350 North Ridge Avenue, Arlington Heights, Illinois 60004-
1412, applied to be registered as an importer of the following basic
class(es) of controlled substance(s):
------------------------------------------------------------------------
Drug
Controlled substance code Schedule
------------------------------------------------------------------------
Cocaine................................ 9041 II
Ecgonine............................... 9180 II
------------------------------------------------------------------------
The company plans to import derivatives of the listed controlled
substances to be used for the manufacture of a diagnostic product and
reference standards. No other activities for these drug codes are
authorized for this registration.
Approval of permit applications will occur only when the
registrant's business activity is consistent with what is authorized
under 21 U.S.C. 952(a)(2). Authorization will not extend to the import
of Food and Drug Administration-approved or non-approved finished
dosage forms for commercial sale.
Matthew Strait,
Deputy Assistant Administrator.
[FR Doc. 2025-02014 Filed 1-30-25; 8:45 am]
BILLING CODE P
